China Life Valuation

CILJF Stock  USD 1.21  0.05  4.31%   
Today, the firm appears to be overvalued. China Life Insurance shows a prevailing Real Value of $1.02 per share. The current price of the firm is $1.21. Our model approximates the value of China Life Insurance from analyzing the firm fundamentals such as Profit Margin of 0.04 %, current valuation of 133.38 B, and Return On Equity of 0.0747 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
1.21
Please note that China Life's price fluctuation is dangerous at this time. Calculation of the real value of China Life Insurance is based on 3 months time horizon. Increasing China Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for China Life Insurance is useful when determining the fair value of the China pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of China Life. Since China Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.21 Real  1.02 Hype  1.21 Naive  1.18
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Life Insurance Company, which is reflected in its stock price. It is based on China Life's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of China Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence China Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.02
Real Value
4.56
Upside
Estimating the potential upside or downside of China Life Insurance helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Life more accurately as focusing exclusively on China Life's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.121.181.23
Details
Hype
Prediction
LowEstimatedHigh
0.061.214.75
Details
Potential
Annual Dividend
LowForecastedHigh
0.030.030.04
Details

China Life Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining China Life's current stock value. Our valuation model uses many indicators to compare China Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Life competition to find correlations between indicators driving China Life's intrinsic value. More Info.
China Life Insurance is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about  0.15  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for China Life Insurance is roughly  6.53 . Comparative valuation analysis is a catch-all model that can be used if you cannot value China Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for China Life's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China Life's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Life and how it compares across the competition.

About China Life Valuation

The pink sheet valuation mechanism determines the current worth of China Life Insurance on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of China Life Insurance. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of China Life Insurance based exclusively on its fundamental and basic technical indicators. By analyzing China Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of China Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of China Life. We calculate exposure to China Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China Life's related companies.
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the Peoples Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance Company Limited. China Life operates under InsuranceLife classification in the United States and is traded on OTC Exchange. It employs 102195 people.

8 Steps to conduct China Life's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Life's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain China Life's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine China Life's revenue streams: Identify China Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research China Life's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish China Life's growth potential: Evaluate China Life's management, business model, and growth potential.
  • Determine China Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Life's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
China Life's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether China Life's value is low or high relative to the company's performance and growth projections. Determining the market value of China Life can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of China Life represents a small ownership stake in the entity. As a stockholder of China, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

China Life Dividends Analysis For Valuation

Please note that China Life has scaled down on payment of dividends at this time.
There are various types of dividends China Life can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of China shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from China Life Insurance directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When China pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of China Life by the value of the dividends paid out.

China Life Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as China Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding28.3 B
Quarterly Earnings Growth Y O Y-0.251
Forward Price Earnings6.3694
Retained Earnings345.7 B
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Life Insurance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for China Pink Sheet analysis

When running China Life's price analysis, check to measure China Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Life is operating at the current time. Most of China Life's value examination focuses on studying past and present price action to predict the probability of China Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Life's price. Additionally, you may evaluate how the addition of China Life to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Please note, there is a significant difference between China Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.